Free Samples in Kansas City, MO: Updated 2026 List for Local Winners
Photo: Abraham Aldaraca / Pexels
See what Missouri's 2026 American Shaman agreement changed—and why no Kansas City winner list or payout exists.
There is no verified 2026 list of Kansas City free-sample winners connected to the American Shaman case. Missouri's June resolution announced no winners, consumer payments, claims process, or giveaway; it required the company to suspend Missouri kratom sales, according to the Missouri Attorney General's June announcement. The confusion appears to come from allegations about free samples containing concentrated 7-hydroxymitragynine, commonly called 7-OH.
Those samples were products offered to consumers, not sweepstakes prizes awarded to selected winners.
What the 2026 records actually show
Missouri filed a petition on March 31 alleging that American Shaman offered free 7-OH samples without addiction disclosures. One example was described as a "2 pack sample." The same filing identified manufacturing or warehousing operations in North Kansas City and Riverside, plus retail locations in Lee's Summit. That places the documented activity across the Kansas City metro, not solely within Kansas City, Missouri, as detailed in the Attorney General's March petition.
The June agreement required Shaman Botanicals, also known as American Shaman, to stop selling any kratom product to Missouri consumers. The restriction covered online and in-store sales, along with Missouri-targeted retail advertising such as billboards.
Is the $5 million figure a consumer payout?
No. The agreement's $5 million amount is a potential penalty that the Attorney General may invoke if Shaman breaches the agreement and fails to correct the breach. It is not a settlement fund for Kansas City residents.
The resolution did not establish eligibility rules, payment amounts, filing deadlines, named winners, or a consumer claim form. The agreement also admits no liability, and no court found the defendants liable. Readers evaluating a post about supposed payments should check whether it identifies: None of those consumer-payment elements appears in the documented June resolution.
- A consumer compensation fund
- Clear eligibility requirements
- A filing deadline and claim procedure
- Language awarding money to consumers rather than imposing a penalty
What product warnings apply?
In July 2025, the FDA stated that concentrated 7-OH is not a lawful dietary supplement or food additive. It is not contained in an FDA-approved drug, and the agency warned that it may be dangerous. Shaman Botanicals was among seven companies that received warning letters.
A separate issue arose in February 2026. Shaman Botanicals voluntarily recalled Alkaloids Chewable Tablets—White Vein nationwide after testing found more 7-OH than the labeled 7.5 milligrams per tablet, creating a risk of a higher dose than intended, according to the FDA recall notice. Broader data requires context.
The CDC recorded 3,434 kratom exposures reported to poison centers in 2025, about 1,200% more than in 2015. However, 79% of 233 reported kratom-associated deaths from 2015 through 2025 involved multiple substances, which limits conclusions about kratom alone, according to the CDC's March 2026 report.
What should Kansas City readers do?
Anyone seeking a winner list or payment should not treat the $5 million penalty as evidence of consumer compensation. The available records describe sales restrictions and enforcement terms, not a giveaway result. Anyone possessing the recalled product should compare its exact name with the FDA notice: Alkaloids Chewable Tablets—White Vein.
The recall concerns a mismatch between the labeled and tested amount of 7-OH, not every product mentioned in the Missouri case. For Missouri consumers, the June agreement's practical effect is straightforward: American Shaman agreed to stop kratom sales online and in stores and cease Missouri-targeted retail advertising.